Repository logo
 
Publication

Urinary proteomic/peptidomic biosignature of breast cancer Patients using 1D SDS-PAGE combined with matrix-assisted laser desorption/ionization-time of flight mass spectrometry

datacite.subject.fosCiências Médicas::Biotecnologia Médica
datacite.subject.fosCiências Naturais::Ciências Químicas
dc.contributor.authorSousa, Patrícia
dc.contributor.authorCamacho, Irene
dc.contributor.authorCâmara, José S.
dc.contributor.authorPerestrelo, Rosa
dc.contributor.authorCamacho, Irene
dc.contributor.authorCâmara, José
dc.contributor.authorPerestrelo, Rosa
dc.date.accessioned2025-08-25T14:47:02Z
dc.date.available2025-08-25T14:47:02Z
dc.date.issued2023-05-05
dc.description.abstract<jats:p>The potential development of a rapid and highly sensitive breast cancer (BC) diagnostic method has been increasingly investigated by many researchers in order to significantly improve the diagnosis of this disease that affects millions of women worldwide. Thus, this investigation aimed to establish a potential BC urinary peptidomic pattern using one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis (1D SDS-PAGE) coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) as a useful approach for BC diagnosis. The results of Lowry’s assay demonstrated that the total protein concentration increased after precipitation and that the healthy control group (HCs, 160 to 318 µg/mL, 142 ± DD µg/mL, on average) presented higher total protein content than the BC patients (140 to 311 µg/mL, 115 ± DD µg/mL, on average). Related to MALDI-TOF MS analysis, the results revealed that four peptide ion biosignatures (m/z 1046.5, 1062.5, 1237.7 and 1727.9) allowed the discrimination between BC patients and HCs. The distinction efficiency and accuracy of BC urine peptides were determined by receiver operating characteristic (ROC) curve analysis that enabled the recognition of some features with great sensitivity (88%) and specificity (98%). Therefore, the obtained data revealed MALDI-TOF MS as a powerful tool to explore peptidomic biosignatures due to its speed, sensitivity, and mass accuracy, which allow the establishment of novel disease biomarkers.</jats:p>eng
dc.identifier.citationSousa, P.; Camacho, I.; Câmara, J.S.; Perestrelo, R. Urinary Proteomic/Peptidomic Biosignature of Breast Cancer Patients Using 1D SDS-PAGE Combined with Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry. Separations 2023, 10, 291. https://doi.org/10.3390/ separations10050291
dc.identifier.doi10.3390/separations10050291
dc.identifier.issn2297-8739
dc.identifier.urihttp://hdl.handle.net/10400.13/7344
dc.language.isoeng
dc.peerreviewedyes
dc.publisherMDPI
dc.relationMadeira Chemistry Research Centre
dc.relationMadeira Chemistry Research Centre
dc.relation.ispartofSeparations
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectBiomarkers
dc.subjectBreast cancer
dc.subject1D SDS-PAGE
dc.subjectMALDI-TOF MS
dc.subjectUrine peptidomic
dc.subject.
dc.subjectCentro de Química da Madeira
dc.subjectFaculdade de Ciências da Vida
dc.subjectFaculdade de Ciências Exatas e da Engenharia
dc.titleUrinary proteomic/peptidomic biosignature of breast cancer Patients using 1D SDS-PAGE combined with matrix-assisted laser desorption/ionization-time of flight mass spectrometryeng
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleMadeira Chemistry Research Centre
oaire.awardTitleMadeira Chemistry Research Centre
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00674%2F2020/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDP%2F00674%2F2020/PT
oaire.citation.issue5
oaire.citation.titleSeparations
oaire.citation.volume10
oaire.fundingStream6817 - DCRRNI ID
oaire.fundingStream6817 - DCRRNI ID
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85
person.familyNameCamacho
person.familyNameCâmara
person.familyNamePerestrelo
person.givenNameIrene
person.givenNameJosé
person.givenNameRosa
person.identifierG-3003-2013
person.identifier1441319
person.identifier.ciencia-id481C-08CE-90E5
person.identifier.ciencia-id251A-D5F7-9E32
person.identifier.orcid0000-0003-0061-905X
person.identifier.orcid0000-0003-1965-3151
person.identifier.orcid0000-0002-7223-1022
person.identifier.ridI-2307-2014
person.identifier.scopus-author-id56374101100
person.identifier.scopus-author-id10140393000
person.identifier.scopus-author-id16686828800
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
relation.isAuthorOfPublication5b2a49ac-c192-4d42-80f8-28efc578f53e
relation.isAuthorOfPublicatione10d78be-e547-4d25-92b5-06a997ed78da
relation.isAuthorOfPublication003ff241-47d2-497b-b9ac-c0d1713f8bf3
relation.isAuthorOfPublication.latestForDiscovery5b2a49ac-c192-4d42-80f8-28efc578f53e
relation.isProjectOfPublicatione30e13d9-be9a-4f34-91ea-a1682abce74e
relation.isProjectOfPublicatione64ad36a-83b5-467c-bbb3-449ffc0662f2
relation.isProjectOfPublication.latestForDiscoverye30e13d9-be9a-4f34-91ea-a1682abce74e

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Urinary Proteomic.pdf
Size:
5.32 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.03 KB
Format:
Item-specific license agreed upon to submission
Description: